1. Home
  2. KNSA vs GEL Comparison

KNSA vs GEL Comparison

Compare KNSA & GEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KNSA
  • GEL
  • Stock Information
  • Founded
  • KNSA 2015
  • GEL 1996
  • Country
  • KNSA United Kingdom
  • GEL United States
  • Employees
  • KNSA N/A
  • GEL N/A
  • Industry
  • KNSA Biotechnology: Pharmaceutical Preparations
  • GEL Oil Refining/Marketing
  • Sector
  • KNSA Health Care
  • GEL Energy
  • Exchange
  • KNSA Nasdaq
  • GEL Nasdaq
  • Market Cap
  • KNSA 1.9B
  • GEL 1.6B
  • IPO Year
  • KNSA 2018
  • GEL 1996
  • Fundamental
  • Price
  • KNSA $27.36
  • GEL $15.79
  • Analyst Decision
  • KNSA Strong Buy
  • GEL Buy
  • Analyst Count
  • KNSA 5
  • GEL 3
  • Target Price
  • KNSA $38.80
  • GEL $16.50
  • AVG Volume (30 Days)
  • KNSA 474.9K
  • GEL 471.3K
  • Earning Date
  • KNSA 07-22-2025
  • GEL 05-08-2025
  • Dividend Yield
  • KNSA N/A
  • GEL 4.18%
  • EPS Growth
  • KNSA N/A
  • GEL N/A
  • EPS
  • KNSA N/A
  • GEL N/A
  • Revenue
  • KNSA $481,166,000.00
  • GEL $2,930,080,000.00
  • Revenue This Year
  • KNSA $37.21
  • GEL N/A
  • Revenue Next Year
  • KNSA $5.32
  • GEL $5.69
  • P/E Ratio
  • KNSA N/A
  • GEL N/A
  • Revenue Growth
  • KNSA 59.45
  • GEL 3.87
  • 52 Week Low
  • KNSA $17.38
  • GEL $9.86
  • 52 Week High
  • KNSA $28.56
  • GEL $16.79
  • Technical
  • Relative Strength Index (RSI)
  • KNSA 62.48
  • GEL 58.20
  • Support Level
  • KNSA $26.28
  • GEL $15.10
  • Resistance Level
  • KNSA $27.90
  • GEL $15.58
  • Average True Range (ATR)
  • KNSA 0.99
  • GEL 0.57
  • MACD
  • KNSA -0.07
  • GEL 0.06
  • Stochastic Oscillator
  • KNSA 82.30
  • GEL 58.30

About KNSA Kiniksa Pharmaceuticals Ltd.

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.

About GEL Genesis Energy L.P. Common Units

Genesis Energy LP is a limited partnership company that focuses on the midstream segment of the crude oil and natural gas industry. It engages in providing services to crude oil and natural gas producers, and industrial and commercial enterprises. The company's reportable segments are offshore pipeline transportation, sodium minerals, and sulfur services, onshore facilities and transportation, and marine transportation. It generates maximum revenue from the offshore pipeline transportation segment which conducts crude oil and natural gas pipeline transportation and handling operations in the Gulf of Mexico through its offshore pipeline transportation segment, which focuses on providing a suite of services to integrated and large independent energy companies.

Share on Social Networks: